¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Neurological devices associated with adverse incidents"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® adverse effect ÇÑ±Û ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
¼³¸í   
  ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇϴ °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇϴ Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, Æ¯È÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀΠ¿ªÈ¿°ú·Î¼­ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • delayed ischemic neurological deficit
    Áö¿¬ÇãÇ÷½Å°æÇÐÀû°á¼Õ
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • adverse action
    À¯ÇØÀÛ¿ë
  • adverse drug reaction
    ¾à¹°À¯ÇعÝÀÀ
  • adverse effect
    À¯ÇØÈ¿°ú
  • adverse reaction
    À¯ÇعÝÀÀ
  • antibiotic-associated
    Ç×»ýÁ¦°ü·Ã-
  • associated defect
    ¿¬°üÀå¾Ö
  • associated movement
    ¿¬Çտ
  • associated reaction
    ¿¬ÇÕ¹ÝÀÀ
  • adeno-associated satellite virus
    ¾Æµ¥³ë°ü·ÃÀ§¼º¹ÙÀÌ·¯½º
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·çÇÁ°ü·Ã¹ÙÀÌ·¯½º
  • cell-associated antibody
    ¼¼Æ÷¿¬°üÇ×ü
  • gut-associated lymphatic tissue
    âÀÚ¿¬°ü¸²ÇÁÁ¶Á÷, À忬°ü¸²ÇÁÁ¶Á÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adverse action
    À¯ÇØÀÛ¿ë
  • adverse effect
    (¢¡ adverse event) À¯ÇذæÇè
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • delayed ischemic neurological deficit
    Áö¿¬ÇãÇ÷½Å°æ°áÇÔ
  • neurological disorder
    ½Å°æ°èÀå¾Ö, ½Å°æ°èÁúȯ
  • soft neurological sign
    ¿¬¼º½Å°æÇСÈÄ
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse reaction
    ºÎÀÛ¿ë
  • adverse selection
    ¿ª¼±ÅÃ
  • adverse action
    À¯ÇØÀÛ¿ë
  • adverse drug reaction
    ¾à¹°ºÎÀÛ¿ë
  • antibiotic-associated
    Ç×»ýÁ¦°ü·Ã-
  • adeno-associated virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀÇÁ¸¹ÙÀÌ·¯½º
  • associated defect
    ¿¬ÇÕ°áÇÔ, ¿¬ÇÕ°á¼Õ, ¼ö¹ÝÀå¾Ö
  • associated movement
    ¿¬Çտ
  • associated reaction
    ¿¬ÇÕ¹ÝÀÀ
  • cell-associated antibody
    ¼¼Æ÷ºÎÂøÇ×ü
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Intrauterine devices
    Àڱó»ÀåÄ¡(í­ÏàÒ®íûöÇ)
  • I region-associated antigen
    Ir¿¬°üÇ׿ø
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã(¡­Î¼æá) ¹ÙÀÌ·¯½º.
  • adeno-associated virus
    ¾Æµ¥³ë°ü·Ã(¡­Î¼æá) ¹ÙÀÌ·¯½º.
  • adeno-associated virus
    ¾Æµ¥³ë(¹ÙÀÌ·¯½º) ÀÇÁ¸ ¹ÙÀÌ·¯½º
  • age-associated memory impairment
    ¿¬·É°ü·Ã ±â¾ï·Â Àå¾Ö(¼Õ»ó)
  • antibiotic-associated colitis/diarrhea
    Ç×»ýÁ¦À¯¹ß´ëÀå¿°, Ç×»ýÁ¦À¯¹ß¼³»ç
  • antigen,fetal tumor-associated
    žÆÁ¾¾ç °ü·Ã¼º(÷Ãä®ðþåË Î¼Ö¤àõ)
  • gut-associated lymphatic tissue (GALT)
    Àå-¿¬°ü ¸²ÇÁÁ¶Á÷
  • ADR : adverse drug reaction
    ¾à¹°À¯ÇØÀÛ¿ë(å·ÚªêóúªíÂéÄ).
  • adverse action
    À¯ÇØ(êóúª)ÀÛ¿ë.
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse event
    À¯ÇØ»ç·Ê(êóúªÞÀçÓ).
  • adverse reaction
    À¯ÇØ(êóúª)¹ÝÀÀ, ¿ª(æ½)¹ÝÀÀ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • devices
    ÀåÄ¡¡ì±â°èÀåÄ¡¡í, º¸À屸(ÜÍíûÎý), °í¾È.
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺΰüÀý ÁõÈıº
  • neurological disorder
    ½Å°æ°èÀå¾Ö.
  • soft neurological signs
    ¿¬¼º ½Å°æÇÐÀû ¡ÈÄ
  • adverse action
    À¯ÇØ(êóúª)ÀÛ¿ë.
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse effect
    ¿ªÈ¿°ú(æ½üùÍý).¾à¸®À¯ÇØÈ¿°ú.
  • adverse event
    À¯ÇØ»ç·Ê(êóúªÞÀçÓ).
  • adverse reaction
    ºÎÀÛ¿ë
  • adverse reaction
    À¯ÇØ(êóúª)¹ÝÀÀ, ¿ª(æ½)¹ÝÀÀ.
  • adverse reactions
    ºÎÀÛ¿ë
  • adverse selection
    ¿ª¼±ÅÃ.
  • drug reactions, adverse
    ¾à¹°¹ÝÀÀ(¡­Úãëë), ºÎÀÛ¿ë(ÜùíÂéÄ)
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ºÎÀÛ¿ë
  • untoward effect =adverse reaction, unwanted reaction
    À¯ÇعÝÀÀ(êóúªÚãëë), ¾àÇØ(å·úª)¹ÝÀÀ.[¾à¸®]ºÎÀÛ¿ë, ºÒ¿øÀÛ¿ë.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adenovirus-associated virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½º¿¬°è(ææÍ¨) ¹ÙÀÌ·¯½º
  • I region-associated protein
    I ºÎÀ§¿¬°ü(Ý»êÈ֤μ) ´Ü¹éÁú(Ó±ÛÜòõ)
  • microtubule-associated proteins
    ¹Ì¼Ò°ü ¿¬°ü´Ü¹éÁú(Ú°á³Î·æáμӱÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • MALT(mucosa associated lymphoid tissue)
    Á¡¸·°ü·Ã¸²ÇÁÁ¶Á÷
  • neurological disorder
    ½Å°æ°èÀå¾Ö
  • adverse action
    À¯ÇØÀÛ¿ë
  • adverse effect
    ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
  • adverse reaction
    ºÎÀÛ¿ë, À¯ÇعÝÀÀ, À¯ÇØÀÛ¿ë, ¿ª¹ÝÀÀ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IUCD Intra-Uterine Contraceptive Devices; Àڱó» ÇÇÀÓ ÀåÄ¡
  = IUD
CDRH Center for Devices and Radiological Health
MDMU medical devices for military use
SMDA Safe Medical Devices Act [of 1990]; starch methylenedianiline
ADE acute disseminated encephalitis; adverse drug event; antibody-dependent enhancement; apparent digest...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CDRH Center for Devices and Radiological Health
CVAD Central venous access devices
SCD Sequential Compression Devices
VAD Venous access devices
the SMDA the Safe Medical Devices Act of 190
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y75
    Neurological devices associated with adverse incidents
    À¯ÇØ»ç°Ç°ú °ü·ÃµÈ ½Å°æ°ú ÀåÄ¡
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic infantile neurological cutaneous articular syndrome
    ¸¸¼º À¯¾Æ ½Å°æ ÇǺαº
  • National Institute of Neurological Diseaseand Blindness
    ½Å°æ Áúȯ ¹× ½Ç¸í ±¹¸³¿¬±¸¼Ò
  • neurological deficit
    ½Å°æ¼º °á¼Õ
  • adverse action
    À¯ÇØÀÛ¿ë
  • adverse drug reaction
    ¾à¹°ÀÇ ºÎÀÛ¿ë
  • adverse event
    À¯ÇØ »ç·Ê
  • adverse loading
    À¯ÇØ ÇÏÁß, ÇØ·Î¿î ÇÏÁß
  • adverse selection
    ¿ª ¼±ÅÃ
  • systemic adverse effect
    Àü½Å¼º ºÎÀÛ¿ë
  • adeno-associated virus
    ¾Æµ¥³ë °ü·Ã ¹ÙÀÌ·¯½º
  • associated
    µ¿¹ÝÀÇ, ¼ö¹ÝÀÇ, °ø¾×ÀÇ, ¿¬ÇÕÀÇ
  • associated symptom
    °ü·Ã Áõ»ó
  • HIV associated periodontal disease
    HIV¿Í °ü·ÃµÈ Ä¡ÁÖ Áúȯ
  • lateral cord and associated anterior cornual syndrome
    Ãø»è µ¿Ãø Àü°¢ ÁõÈıº
  • self-associated rheumatoid factor complex

    self-care (ÀÚ°¡ Ä¡·á

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
models, neurological Theoretical representations that simulate the behaviour or activity of the neurological system, processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment.
(12 Dec 1998)
neurological Of or pertaining to neurolgy.
Source: Websters Dictionary
(01 Mar 1998)
neurological disorder Disturbance in structure or function of the central nervous system resulting from developmental abnormality, disease, injury or toxin.
(22 May 1997)
diagnostic techniques, neurological Methods and procedures for the diagnosis of diseases of the nervous system, central and peripheral, or demonstration of neurologic function or dysfunction.
(12 Dec 1998)
adverse Harmful.
(18 Nov 1997)
adverse drug reaction reporting systems Systems developed for collecting reports from government agencies, manufacturers, hospitals, physicians, and other sources on adverse drug reactions.
(12 Dec 1998)
adverse effect This is an abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness. An effect may be classed as adverse if it causes functional or anatomical damage, causes irreversible change in the homeostasis of the organism, or increases the susceptibility of the organism to other chemical or biological stress. A non-adverse effect will usually be reversed when the organism is no longer being exposed to the chemical.
(09 Oct 1997)
adverse event A toxic reaction to a medical therapy.
(09 Oct 1997)
adverse reaction Any undesirable or unwanted consequence of a preventive, diagnostic, or therapeutic procedure or regimen.
(05 Mar 2000)
no-observed-adverse-effect level The highest dosage administered that does not produce toxic effects. The noael will depend on how closely dosages are spaced (lowest-observed-adverse-effect level and no-observed-effect level) and the number of animals examined. The ultimate objective is usually to determine not the "safe" dosage in laboratory animals but the "safe" dosage for humans. Therefore, the extrapolation most often required of toxicologists is from high-dosage studies in laboratory animals to low doses in humans. (casarett and doull's toxicology: the basic science of poisons, 4th ed)
(12 Dec 1998)
event, adverse In pharmacology, an adverse event is any unexpected or dangerous reaction to a drug.
(12 Dec 1998)
respiratory protective devices Respirators to protect individuals from breathing air contaminated with harmful dusts, fogs, fumes, mists, gases, smokes, sprays, or vapors.
(12 Dec 1998)
computer storage devices Devices capable of receiving data, retaining data for an indefinite or finite period of time, and supplying data upon demand.
(12 Dec 1998)
contraceptive devices Devices that diminish the likelihood of or prevent conception.
(12 Dec 1998)
contraceptive devices, female Contraceptive devices used by females.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurological
    ½Å°æÇлóÀÇ
  • adverse
    ¿ªÀÇ, ºÒ¿îÇÑ, ¹Ý´ëÇÏ´Â
  • associated
    ¿¬ÇÕÇÑ
  • adverse
    ¿ªÀÇ;°Å²Ù·ÎÀÇ;¹Ý´ëÀÇ;ÀûÀǰ¡ ÀÖ´Â;ºÒ¸®ÇÑ
  • associated
    ¿¬ÇÕÇÑ;Á¶ÇÕÀÇ;ÇÕµ¿ÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á